NCCN 2013 Congress Series™: Utilizing Guidelines to Customize Patient Care in Breast Cancer - Management of Early Stage Disease
December 2, 2013
This live activity is an educational program that addresses health care professionals' need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with breast cancer. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most current treatment recommendations for breast cancer.
This activity is designed to meet the educational needs of medical oncologists, radiation oncologists, surgical oncologists, pathologists, nurses, pharmacists, and other healthcare professionals who manage patients with breast cancer.
Following this activity, participants should be able to:
- Evaluate the duration of endocrine therapy in the adjuvant setting and the choice of endocrine therapy in the metastatic setting for patients with hormone receptor positive disease
- List the benefits and risks of adjuvant chemotherapy regimens used in various breast cancer subtypes and the role of gene-based assays in determining the need for chemotherapy
- Identify patients likely to benefit from oral chemotherapy and provide education and assessment of compliance to ensure maximum clinical benefit
Lori J. Goldstein, MD
Fox Chase Cancer Center
This activity is approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits are also provided. View complete accreditation information
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician